Core Viewpoint - Dalian Thermal Power's stock has experienced a decline of 8.84% year-to-date, with a recent drop of 2.11% on November 18, 2023, indicating potential challenges in the company's market performance [1]. Financial Performance - For the period from January to September 2025, Dalian Thermal Power reported operating revenue of 380 million yuan, a year-on-year decrease of 6.32%. The net profit attributable to shareholders was -113 million yuan, reflecting a year-on-year increase of 3.28% [2]. Shareholder Information - As of November 10, 2023, the number of shareholders for Dalian Thermal Power was 39,000, a decrease of 2.50% from the previous period. The average number of tradable shares per shareholder increased by 2.56% to 10,374 shares [2]. Dividend Distribution - Since its A-share listing, Dalian Thermal Power has distributed a total of 186 million yuan in dividends. However, there have been no dividend distributions in the past three years [3]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder of Dalian Thermal Power is the Nuoan Multi-Strategy Mixed A fund, holding 2.5439 million shares, indicating new institutional interest [3].

截至9月30日，沈阳机床股东户数7.50万，较上期减少0.60%；人均流通股22411股，较上期增加0.60%。 2025年1月-9月，沈阳机床实现营业收入25.44亿元，同比增长154.42%；归母净利润114.54万元，同比增 长100.93%。 11月18日，沈阳机床盘中上涨2.05%，截至10:09，报8.47元/股，成交1.68亿元，换手率1.20%，总市值 224.38亿元。 资金流向方面，主力资金净流出1027.02万元，特大单买入981.28万元，占比5.85%，卖出1887.81万元， 占比11.26%；大单买入4418.50万元，占比26.36%，卖出4538.98万元，占比27.08%。 沈阳机床今年以来股价涨19.13%，近5个交易日涨1.68%，近20日涨18.96%，近60日涨25.67%。 资料显示，沈阳机床股份有限公司位于辽宁省沈阳经济技术开发区开发大路17甲1号，成立日期1993年5 月20日，上市日期1996年7月18日，公司主营业务涉及产品研发、机床制造、销售服务、行业解决方 案、机床零部件配套等。主营业务收入构成为：金属切削机床57.38%，金属成形机床29.20%，其 ...

截至9月30日，鞍钢股份股东户数9.57万，较上期减少0.45%；人均流通股0股，较上期增加0.00%。2025 年1月-9月，鞍钢股份实现营业收入730.92亿元，同比减少7.78%；归母净利润-20.40亿元，同比增长 59.87%。 11月18日，鞍钢股份盘中下跌2.15%，截至09:43，报2.73元/股，成交3847.41万元，换手率0.18%，总市 值255.78亿元。 资金流向方面，主力资金净流出415.17万元，特大单买入680.72万元，占比17.69%，卖出954.05万元， 占比24.80%；大单买入641.91万元，占比16.68%，卖出783.75万元，占比20.37%。 鞍钢股份今年以来股价涨13.75%，近5个交易日跌1.80%，近20日跌0.73%，近60日涨1.49%。 资料显示，鞍钢股份有限公司位于辽宁省鞍山市铁西区鞍钢厂区,香港皇后大道中15号置地广场公爵大 厦33楼，成立日期1998年9月14日，上市日期1997年12月25日，公司主营业务涉及黑色金属冶炼及钢压 延加工等。主营业务收入构成为：钢材产品88.87%，其他11.13%。 鞍钢股份所属申万行业为：钢铁-普钢- ...

11月17日，通化金马盘中上涨2.23%，截至11:05，报29.39元/股，成交3.93亿元，换手率1.41%，总市值 284.05亿元。 资金流向方面，主力资金净流出1759.63万元，特大单买入2862.41万元，占比7.28%，卖出4253.98万 元，占比10.82%；大单买入1.15亿元，占比29.36%，卖出1.19亿元，占比30.29%。 通化金马所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：民营医院、工业大麻、 东北振兴、肝炎治疗、中药等。 截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 ...

机构持仓方面，截止2025年9月30日，沈阳机床十大流通股东中，香港中央结算有限公司位居第七大流 通股东，持股1906.66万股，相比上期增加631.82万股。 沈阳机床所属申万行业为：机械设备-通用设备-机床工具。所属概念板块包括：东北振兴、债转股、风 能、国资改革、融资融券等。 截至9月30日，沈阳机床股东户数7.50万，较上期减少0.60%；人均流通股22411股，较上期增加0.60%。 2025年1月-9月，沈阳机床实现营业收入25.44亿元，同比增长154.42%；归母净利润114.54万元，同比增 长100.93%。 分红方面，沈阳机床A股上市后累计派现7190.20万元。近三年，累计派现0.00元。 11月17日，沈阳机床盘中下跌2.00%，截至09:57，报8.31元/股，成交2.09亿元，换手率1.47%，总市值 220.14亿元。 资金流向方面，主力资金净流出917.82万元，特大单买入499.16万元，占比2.39%，卖出646.42万元，占 比3.09%；大单买入5006.06万元，占比23.93%，卖出5776.62万元，占比27.61%。 沈阳机床今年以来股价涨16.88%，近5个 ...

Core Viewpoint - China National Pharmaceutical Group's stock has experienced a decline of 2.06% on November 17, with a current price of 11.41 CNY per share and a total market capitalization of 17.068 billion CNY [1] Financial Performance - For the period from January to September 2025, China National Pharmaceutical achieved a revenue of 25.894 billion CNY, a year-on-year decrease of 0.79%, while the net profit attributable to shareholders was 455 million CNY, reflecting a year-on-year increase of 1.70% [2] - The company has cumulatively distributed dividends of 3.795 billion CNY since its A-share listing, with 725 million CNY distributed over the past three years [3] Stock Market Activity - As of 09:54 on November 17, the trading volume was 137 million CNY, with a turnover rate of 0.80% [1] - The stock has seen a year-to-date increase of 3.77%, a decline of 0.78% over the last five trading days, a rise of 3.92% over the last 20 days, and an increase of 5.16% over the last 60 days [1] Shareholder Information - As of September 30, 2025, the number of shareholders was 139,700, an increase of 0.69% from the previous period, with an average of 10,704 circulating shares per shareholder, a decrease of 0.69% [2] - The top ten circulating shareholders include Southern CSI 500 ETF, holding 10.9137 million shares, down by 170,800 shares from the previous period, and Hong Kong Central Clearing Limited, holding 8.3204 million shares, down by 3.7371 million shares [3] Business Overview - China National Pharmaceutical is primarily engaged in the production, processing, and trade of pharmaceuticals, with its main business revenue composition being 75.50% from pharmaceutical commerce, 13.26% from international trade, and 7.69% from pharmaceutical manufacturing [1]

Core Viewpoint - Tonghua Dongbao's stock price has shown fluctuations, with a recent decline of 2.06% and a year-to-date increase of 15.46% [1] Financial Performance - For the period from January to September 2025, Tonghua Dongbao achieved a revenue of 2.18 billion yuan, representing a year-on-year growth of 50.55% [2] - The net profit attributable to shareholders reached 1.20 billion yuan, marking a significant increase of 1911.35% compared to the previous year [2] Stock Market Activity - As of November 17, the stock price was 9.02 yuan per share, with a market capitalization of 17.67 billion yuan [1] - The trading volume showed a net outflow of 8.44 million yuan from main funds, with large orders reflecting a buy of 11.99 million yuan and a sell of 18.38 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders was 82,100, a decrease of 5.08% from the previous period [2] - The average circulating shares per person increased by 5.35% to 23,843 shares [2] Dividend Distribution - Since its A-share listing, Tonghua Dongbao has distributed a total of 5.51 billion yuan in dividends, with 1.48 billion yuan distributed over the last three years [3] Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, increasing its holdings by 15.84 million shares [3] - The Southern CSI 500 ETF reduced its holdings by 352,900 shares, while the Innovation Drug fund increased its holdings by 486,900 shares [3]

这个发现有多硬核？要知道新中国成立76年来，咱们挖过的最大金矿才500吨级，这次直接翻近三倍！更牛的是勘探周期才用了常规时间的一半，质量却杠 杠的。有网友调侃："这哪是挖矿啊，分明是给地球做B超，还精准定位到了'黄金孕囊'！" "辽宁这回直接整了个大活！"当自然资源部2025年11月14日甩出这个重磅消息时，全国网友的DNA都动了——在辽宁地下2500米深处，勘探队居然挖出了 个"黄金巨无霸"！这个名叫大东沟的金矿床，直接把我国黄金储备的"家底"往上抬了好几个台阶。 先甩组数据让大家感受下什么叫"壕无人性"：25.86亿吨金矿石堆起来，能绕地球赤道转三圈半；1444.49吨黄金资源量，相当于把故宫太和殿的金銮宝座熔 了还能再造3000个；最绝的是平均0.56克/吨的品位，虽然听着不高，但架不住人家量大管饱啊！用地质专家的话说："这就像在沙堆里找米粒，结果挖出个 米仓！" 说到这个"黄金孕囊"的发现过程，那真是比侦探破案还刺激。2023年春天，辽宁省地勘局的"找矿天团"在长白山余脉溜达时，发现某处岩石的"脸色"不太对 ——本该灰扑扑的花岗岩，居然泛着若有若无的金属光泽。这帮"岩石侦探"立马掏出放大镜（其实是便携 ...

Core Insights - The stock price of Dajin Heavy Industry increased by 2.19% on November 14, reaching 47.05 CNY per share, with a total market capitalization of 30.006 billion CNY [1] - The company has seen a significant stock price increase of 131.50% year-to-date, with a recent decline of 0.84% over the last five trading days [1] - Dajin Heavy Industry's main business includes the production and sales of wind power tower frames and thermal power boiler steel structures, with wind power equipment accounting for 94.54% of its revenue [1] Financial Performance - For the period from January to September 2025, Dajin Heavy Industry reported a revenue of 4.595 billion CNY, representing a year-on-year growth of 99.25%, and a net profit attributable to shareholders of 888 million CNY, up 214.63% year-on-year [2] - The company has distributed a total of 325 million CNY in dividends since its A-share listing, with 240 million CNY distributed over the past three years [3] Shareholder Structure - As of October 31, 2025, the number of shareholders for Dajin Heavy Industry increased to 67,300, a rise of 15.29%, while the average number of tradable shares per shareholder decreased by 13.26% to 9,381 shares [2] - The second-largest shareholder is Hong Kong Central Clearing Limited, holding 22.0823 million shares, an increase of 2.6702 million shares from the previous period [3] - New institutional shareholders include Southern CSI 1000 ETF and Dongfanghong Qiyuan Three-Year Holding Mixed A, which have entered the top ten circulating shareholders list [3]

一汽解放今年以来股价跌7.48%，近5个交易日涨3.01%，近20日涨8.18%，近60日涨8.02%。 资料显示，一汽解放集团股份有限公司位于吉林省长春市汽车开发区东风大街2259号，成立日期1997年 6月10日，上市日期1997年6月18日，公司主营业务涉及商用车整车的研发、生产和销售。主营业务收入 构成为：商用车92.89%，备品及其他7.11%。 11月14日，一汽解放盘中上涨2.03%，截至09:37，报7.54元/股，成交5429.90万元，换手率0.15%，总市 值371.06亿元。 资金流向方面，主力资金净流入496.86万元，特大单买入597.74万元，占比11.01%，卖出611.04万元， 占比11.25%；大单买入1212.24万元，占比22.33%，卖出702.08万元，占比12.93%。 分红方面，一汽解放A股上市后累计派现100.55亿元。近三年，累计派现9.40亿元。 机构持仓方面，截止2025年9月30日，一汽解放十大流通股东中，香港中央结算有限公司位居第六大流 通股东，持股3553.57万股，相比上期减少257.04万股。华泰柏瑞沪深300ETF（510300）位居第八大 ...